Author
Number of items: 5.
Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis. (2007)
Tracy Garnier,
Antti Mantyla,
Tomi Jarvinen,
M. Jayne Lawrence,
Marc Brown
and
Simon L. Croft
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. (2007)
T. Garnier,
A. Mantyla,
T. Jarvinen,
J. Lawrence,
Marc Brown
and
S.L. Croft
![]()
In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. (2006)
Tracy Garnier,
Marc Brown,
M. Jayne Lawrence
and
Simon L. Croft
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone. (2004)
A. Mantyla,
T. Garnier,
J. Rautio,
T. Nevalainen,
J. Vepsalainen,
A. Koskinen,
S.L. Croft
and
T. Jarvinen
Topical treatment for cutaneous leishmaniasis. (2002)
T. Garnier
and
S.L. Croft
![]()